Descrizione Clinica
Igiene intimate Defensen+ 7cpr vaginal
DIFESAN+
Description
Medical device Class IIA. Disposable.
Useful treatment for maintaining and controlling the physiological environment of the cervical-vaginal mucosa, to be used in all cases of temporary alteration of the vaginal microbial balance.
Indicated as a coadjuvant for the maintenance of the physiological environment of the cervical-vaginal mucosa, it is useful for the prevention and treatment of cervical-vaginal infections and alterations that can arise during pregnancy and which can cause premature breakage of the membranes, the PROM, the uterine cervix, and for the prevention of preterminal birth.
It can be useful:
- as a coadjuvant in the prevention of miscarriage and childbirth;
- as an adjuvant in prevention against increased risk of abortion related to invasive procedures such as Amniocentesis or Villocentesis;
- as a coadjuvant treatment useful in the prevention of preterminal birth in the presence of cervicometria reduced or not corresponding to the gestational period;
- as an adjuvant in the prevention and treatment of female infertility.
Mode of use
After carefully washing your hands, take a single tablet from the blister. Gently introduce the tablet into the vagina as deeply as possible. To facilitate the introduction of the vaginal tablet, it is suggested to place in supine position, slightly bent legs. The treatment should be properly initiated and concluded in the intermenstrual period or according to different medical indication.
Components
Lactoferrin, Microcrystalline cellulose, Mannitol, Croscaramellose carbossimetilcellulose, Magnesium vegetable stearate, HPMC, Glicerol, Silicon dioxide.
Warnings
Disposable; do not reuse. The product is for vaginal use. Don't swallow. Do not use in case of hypersensitivity and incompatibility towards any product component. The tests carried out on the product to date, did not highlight any sensitization phenomena or other side effects. In case of the appearance of persistent discomfort consult your doctor. May contain lactose. Studies relating to the use of the vaginal tablet in conjunction with local pharmacological therapies are not available. The product is not intended for pediatric use. The treatment should be properly initiated and concluded in the intermenstrual period or according to different medical indication. The maximum duration of continuous treatment is 30 days. Prolonged use of the product, such as for all topical products, may result in local sensitization or irritation phenomena, where this may interrupt treatment and consult your doctor or pharmacist. Do not use the product if the packaging at the time of the first opening is damaged or not perfectly integrated. Use the product in accordance with the instructions. Keep the product out of sight and reach of children. Do not use the product after the expiry date indicated on the packaging.
Conservation
Store at room temperature.
Validity of packaging: 24 months.
Format
Blister from 7 vaginal tablets from 0.9 g.
Net weight: 6.3 g.
Medical device Class IIA. Disposable.
Useful treatment for maintaining and controlling the physiological environment of the cervical-vaginal mucosa, to be used in all cases of temporary alteration of the vaginal microbial balance.
Indicated as a coadjuvant for the maintenance of the physiological environment of the cervical-vaginal mucosa, it is useful for the prevention and treatment of cervical-vaginal infections and alterations that can arise during pregnancy and which can cause premature breakage of the membranes, the PROM, the uterine cervix, and for the prevention of preterminal birth.
It can be useful:
- as a coadjuvant in the prevention of miscarriage and childbirth;
- as an adjuvant in prevention against increased risk of abortion related to invasive procedures such as Amniocentesis or Villocentesis;
- as a coadjuvant treatment useful in the prevention of preterminal birth in the presence of cervicometria reduced or not corresponding to the gestational period;
- as an adjuvant in the prevention and treatment of female infertility.
Mode of use
After carefully washing your hands, take a single tablet from the blister. Gently introduce the tablet into the vagina as deeply as possible. To facilitate the introduction of the vaginal tablet, it is suggested to place in supine position, slightly bent legs. The treatment should be properly initiated and concluded in the intermenstrual period or according to different medical indication.
Components
Lactoferrin, Microcrystalline cellulose, Mannitol, Croscaramellose carbossimetilcellulose, Magnesium vegetable stearate, HPMC, Glicerol, Silicon dioxide.
Warnings
Disposable; do not reuse. The product is for vaginal use. Don't swallow. Do not use in case of hypersensitivity and incompatibility towards any product component. The tests carried out on the product to date, did not highlight any sensitization phenomena or other side effects. In case of the appearance of persistent discomfort consult your doctor. May contain lactose. Studies relating to the use of the vaginal tablet in conjunction with local pharmacological therapies are not available. The product is not intended for pediatric use. The treatment should be properly initiated and concluded in the intermenstrual period or according to different medical indication. The maximum duration of continuous treatment is 30 days. Prolonged use of the product, such as for all topical products, may result in local sensitization or irritation phenomena, where this may interrupt treatment and consult your doctor or pharmacist. Do not use the product if the packaging at the time of the first opening is damaged or not perfectly integrated. Use the product in accordance with the instructions. Keep the product out of sight and reach of children. Do not use the product after the expiry date indicated on the packaging.
Conservation
Store at room temperature.
Validity of packaging: 24 months.
Format
Blister from 7 vaginal tablets from 0.9 g.
Net weight: 6.3 g.
